NRIX icon

Nurix Therapeutics
NRIX

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$27
174% upside
High target

4 analyst ratings

positive
1  neutral
25%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Morgan Stanley
Morgan Stanley
Terence Flynn
14 Oct ‘25 3 days ago
HC Wainwright & Co
HC Wainwright & Co
Robert Burns
33% 1-yr NRIX win rate
14 Oct ‘25 3 days ago
Piper Sandler
Piper Sandler
Joseph Catanzaro
0% 1-yr NRIX win rate
10 Oct ‘25 7 days ago
Oppenheimer
Oppenheimer
Matthew Biegler
0% 1-yr NRIX win rate
10 Oct ‘25 7 days ago